WNY Asset Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-5,692
Closed -$631K 245
2025
Q2
$631K Sell
5,692
-4,814
-46% -$512K 0.07% 119
2025
Q1
$1.18M Sell
10,506
-8,959
-46% -$924K 0.14% 79
2024
Q4
$1.8M Sell
19,465
-14,446
-43% -$1.3M 0.22% 57
2024
Q3
$2.84M Sell
33,911
-18,952
-36% -$1.45M 0.33% 47
2024
Q2
$3.63M Buy
52,863
+19,071
+56% +$1.27M 0.48% 40
2024
Q1
$2.48M Buy
33,792
+3,068
+10% +$236K 0.38% 50
2023
Q4
$2.49M Buy
30,724
+3,917
+15% +$305K 0.42% 46
2023
Q3
$2.01M Buy
26,807
+5,702
+27% +$439K 0.39% 51
2023
Q2
$1.63M Sell
21,105
-2,669
-11% -$213K 0.35% 47
2023
Q1
$1.97M Sell
23,774
-9,683
-29% -$802K 0.47% 46
2022
Q4
$2.87M Sell
33,457
-23,504
-41% -$1.86M 0.78% 32
2022
Q3
$3.51M Buy
56,961
+7,106
+14% +$448K 1.27% 23
2022
Q2
$3.08M Buy
49,855
+7,461
+18% +$462K 1.04% 26
2022
Q1
$2.53M Buy
42,394
+13,104
+45% +$838K 0.78% 35
2021
Q4
$2.13M Buy
29,290
+6,699
+30% +$461K 0.63% 39
2021
Q3
$1.57M Sell
22,591
-1,125
-5% -$79K 0.54% 44
2021
Q2
$1.63M Buy
23,716
+9,481
+67% +$633K 0.58% 37
2021
Q1
$920K Buy
+14,235
New +$918K 0.37% 54

Other funds holding GILD

WNY Asset Management's GILD Position: Q3 2025 in Review

WNY Asset Management sold out of Gilead Sciences (GILD) in Q3 2025, closing a stake of 5,692 shares — an estimated $631K sold.

WNY Asset Management first reported a position in GILD in Q1 2021 and held it in 18 quarters. The position peaked at $3.63M in Q2 2024. 2,026 funds tracked by Wall St. Rank hold GILD as of Q3 2025.

  • WNY Asset Management reported no remaining Gilead Sciences position as of Q3 2025 after selling out during the quarter.
  • WNY Asset Management sold 5,692 Gilead Sciences shares in Q3 2025, an estimated $631K.
  • WNY Asset Management first reported a position in Gilead Sciences in Q1 2021 and held it in 18 quarters.
  • WNY Asset Management's Gilead Sciences position peaked at $3.63M in Q2 2024.
  • 2,026 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2025.

Based on WNY Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.